World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01252212
Date of registration: 30/11/2010
Primary sponsor: University of California, San Francisco
Public title: Adherence, Improvement Measure (AIM) System AIM
Scientific title: Adherence, Improvement Measure (AIM) System; Challenge Topic: 10-MH-101
Date of first enrolment: August 2010
Target sample size: 250
Recruitment status: Active, not recruiting
URL:  http://clinicaltrials.gov/show/NCT01252212
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research  
Countries of recruitment
United States
Contacts
Name:   James Kahn, MD
Address: 
Telephone:
Email:
Affiliation:  University of California, San Francisco
Key inclusion & exclusion criteria

Inclusion Criteria:

- Older than 18

- Evidence of HIV-1 infection, based on patient's medical history or results of
laboratory tests

- Detectable Viral Load, based on patient's medical record

- Receiving primary medical care at the AIDS Program at SFGH

- Able and willing to give informed consent to be randomized to study arms

- Willing to use the patient portal

- Has a cell phone with ability to receive and send unlimited SMS texts, Patient of the
HIV/AIDS Clinic at ward 86, SFGH

Exclusion Criteria:

Failure to meet inclusion criteria

-



Age minimum: 18 Years
Age maximum: N/A
Gender: Both
Health Condition(s) or Problem(s) studied
AIDS
Patient Compliance
Intervention(s)
Behavioral: No SMS adherence reminder
Behavioral: SMS medication adherence
Primary Outcome(s)
HIV viral load [Time Frame: 12 month]
Secondary Outcome(s)
Level of antiretroviral medication in hair [Time Frame: 12 month]
Secondary ID(s)
10-00019
1RC1MH088341
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Agency for Healthcare Research and Quality (AHRQ)
National Institute of Mental Health (NIMH)
The Commonwealth Fund
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history